http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-61430-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_794de22e450322c3f035c1064d883a8a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30 |
| filingDate | 1994-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66afcb94ec166bd687628ece50a009fd |
| publicationDate | 1997-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BG-61430-B1 |
| titleOfInvention | ANTIASTATIC MEDICINES |
| abstract | An anti-asthmatic drug comprising the following compounds in mg: atropinsulphate 0.25-2.00; papaverine hydrochloride 30.00 to 200.00; pure caffeine from 30.00 to 250.00; ergotamintartrate 0.25-2.00; zinc sulphate from 10.00 to 400.00 and sex hormone from 0.25 to 5.00. |
| priorityDate | 1994-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.